Riluzole preserves brain endothelial integrity in ischemic stroke via SLC7A11-dependent GPX4 and HIF-1α/VEGFA signaling
Cellular Signalling · 2026
DOI: 10.1016/j.cellsig.2026.112378 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2026. Verfasst von Haipeng Wang und 14 weiteren Autor:innen. Beteiligte Einrichtung: College of Biomedicine and Health, College of Life Science and Technology, Huazhong Agricultural University, Wuhan 430070, Hubei, China. Hauptthemen laut MEDLINE: Hypoxia-Inducible Factor 1, alpha Subunit, Signal Transduction, Riluzole, Amino Acid Transport System y+. Die Arbeit nennt 53 Literaturangaben. Gefördert von: Key Research and Development Project of Hainan Province, Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.
Themen: Schlaganfall
Abstract (Originalsprache)
Riluzole, an FDA-approved neuroprotective agent, was investigated for its therapeutic potential in ischemic stroke. Transcriptomic profiling of human brain microvascular endothelial cells (hBMECs) subjected to oxygen-glucose deprivation/reperfusion (OGD/R) identified a pivotal role for the cystine/glutamate antiporter SLC7A11. We found that riluzole activates SLC7A11, thereby triggering a dual protective mechanism: it strengthens cellular antioxidant capacity by upregulating GPX4 while simultaneously enhancing proangiogenic signaling through the HIF-1α/VEGFA pathway. Consequently, riluzole attenuated OGD/R-induced endothelial injury and, in a mouse stroke model, reduced blood-brain barrier disruption and improved neurological outcomes. Our study reveals a previously unrecognized cerebrovascular protective mechanism of riluzole, establishing SLC7A11 as its key mediator. This SLC7A11-dependent dual-pathway action represents a substantive advance in understanding riluzole's therapeutic biology beyond its established roles in the central nervous system.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Biomedicine and Health, College of Life Science and Technology, Huazhong Agricultural University, Wuhan 430070, Hubei, China.
- College of Biomedicine and Health, College of Life Science and Technology, Huazhong Agricultural University, Wuhan 430070, Hubei, China; Hubei Clinical Research Center of Central Nervous System Repair and Functional Rec…
- Department of Neurology, Taihe Hospital, Hubei University of Medicine, Shiyan 442000, Hubei, China.
- Department of Electrical and Electronic Engineering, School of Engineering Cardiff University, Cardiff CF24 3AA, UK.
- Department of Neurology, Xiangyang No.1 People's Hospital, Hubei University of Medicine, Xiangyang 441000, Hubei, China. Electronic address: zhoupeiyang@126.com.
Förderung
- Key Research and Development Project of Hainan Province
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- Natural Science Foundation of Hubei Province
Zitieren
APA
Wang, H., Feng, Y., Jiang, W., Wang, H., Zhang, R., Li, G., Duan, C., Zhou, Y., Bao, W., Shui, K., Zhang, M., Ai, Z., Yang, X., Zhou, P., & Dong, Z. (2026). Riluzole preserves brain endothelial integrity in ischemic stroke via SLC7A11-dependent GPX4 and HIF-1α/VEGFA signaling. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2026.112378
Vancouver
Wang H, Feng Y, Jiang W, Wang H, Zhang R, Li G, et al. Riluzole preserves brain endothelial integrity in ischemic stroke via SLC7A11-dependent GPX4 and HIF-1α/VEGFA signaling. Cellular Signalling. 2026. doi:10.1016/j.cellsig.2026.112378
BibTeX
@article{Wang2026,
author = {Wang, Haipeng and Feng, Ying and Jiang, Wei and Wang, Han and Zhang, Ruolin and Li, Guangqiang and Duan, Chao and Zhou, Yuneng and Bao, Wendai and Shui, Ke and Zhang, Min and Ai, Zhibing and Yang, Xin and Zhou, Peiyang and Dong, Zhiqiang},
title = {Riluzole preserves brain endothelial integrity in ischemic stroke via SLC7A11-dependent GPX4 and HIF-1α/VEGFA signaling},
journal = {Cellular Signalling},
year = {2026},
doi = {10.1016/j.cellsig.2026.112378}
}
EUVIMED